220 related articles for article (PubMed ID: 18180534)
1. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
Chen JP
J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
[TBL] [Abstract][Full Text] [Related]
2. Use of SafeCut Balloon for treatment of in-stent restenosis of a previously underexpanded sirolimus-eluting stent with a heavily calcified plaque.
Otsuka Y; Kasahara Y; Kawamura A
J Invasive Cardiol; 2007 Dec; 19(12):E359-62. PubMed ID: 18180527
[TBL] [Abstract][Full Text] [Related]
3. Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
Ponnuthurai FA; van Gaal WJ; Channon KM
J Invasive Cardiol; 2007 Dec; 19(12):E369-71. PubMed ID: 18180530
[TBL] [Abstract][Full Text] [Related]
4. Very late stent thrombosis after bare-metal stent implantation: case reports and review of the literature.
Lemesle G; Pinto Slottow TL; Waksman R
J Invasive Cardiol; 2009 Feb; 21(2):E27-32. PubMed ID: 19182301
[TBL] [Abstract][Full Text] [Related]
5. Occlusion of the saphenous vein graft at the site of polytetrafluoroethylene membrane-covered stent implantation: was it late thrombosis?
Toutouzas K; Takagi T; Colombo A
J Invasive Cardiol; 2003 Dec; 15(12):722-4. PubMed ID: 14660828
[No Abstract] [Full Text] [Related]
6. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
Zhang F; Qian J; Ge J
J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
[TBL] [Abstract][Full Text] [Related]
7. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy.
Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381
[TBL] [Abstract][Full Text] [Related]
8. Very late [corrected] thrombosis of a sirolimus-eluting stent.
Henderson D; Gunalingam B
Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
[TBL] [Abstract][Full Text] [Related]
9. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
10. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
Young JJ
Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
[TBL] [Abstract][Full Text] [Related]
11. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
[TBL] [Abstract][Full Text] [Related]
12. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
Sacha J; Wester A; Pluta W
Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
[TBL] [Abstract][Full Text] [Related]
13. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.
Pfisterer M; Brunner-La Rocca HP; Rickenbacher P; Hunziker P; Mueller C; Nietlispach F; Leibundgut G; Bader F; Kaiser C;
Eur Heart J; 2009 Jan; 30(1):16-24. PubMed ID: 19033260
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
15. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
16. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials.
Sanchez-Recalde A; Moreno R; Barreales L; Rivero F; Galeote G; Jimenez-Valero S; Calvo L; López de Sá E; López-Sendón JL
J Invasive Cardiol; 2008 Aug; 20(8):417-22. PubMed ID: 18688067
[TBL] [Abstract][Full Text] [Related]
17. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).
Sheiban I; Sillano D; Biondi-Zoccai G; Chieffo A; Colombo A; Vecchio S; Margheri M; Gunn JP; Raina T; Liistro F; Bolognese L; Lee MS; Tobis J; Moretti C
J Am Coll Cardiol; 2009 Sep; 54(13):1131-6. PubMed ID: 19761932
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
19. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
20. New drug-eluting stent platforms to prevent stent thrombosis.
Kereiakes DJ
Rev Cardiovasc Med; 2007; 8 Suppl 1():S34-43. PubMed ID: 17401310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
